LYSVULPEN - por. ad us. vet.
LYSVULPEN - por. ad us. vet.
Authorised
- Rabies virus, strain SAD, Live
Product identification
Medicine name:
LYSVULPEN - por. ad us. vet.
Active substance:
- Rabies virus, strain SAD, Live
Target species:
-
Fox
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rabies virus, strain SAD, Live6.00/log10 50% cell culture infectious dose1.00millilitre(s)
Pharmaceutical form:
-
Capsule
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07BD
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Package description:
- Available only in Bulgarian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-1737-03.04.2012
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
